Accuray Incorporated (ARAY) News
Filter ARAY News Items
ARAY News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ARAY News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest ARAY News From Around the Web
Below are the latest news stories about ACCURAY INC that investors may wish to consider to help them evaluate ARAY as an investment opportunity.
Are Medical Stocks Lagging Aptevo Therapeutics (APVO) This Year?Here is how Aptevo Therapeutics Inc. (APVO) and Accuray (ARAY) have performed compared to their sector so far this year. |
Here's Why You Should Add Accuray Stock to Your Portfolio NowARAY's solid product demand and revenue growth raise optimism about the stock. |
3 Penny Stocks On US Exchanges With Market Caps Up To $2BAs the U.S. stock market rebounds from a sluggish start to 2025, investors are eyeing opportunities amid renewed optimism in major indices. Penny stocks, though often associated with high risk due to their smaller size and less-established nature, can still present valuable opportunities when backed by strong financials. By focusing on companies with solid balance sheets and potential for growth, investors may uncover promising prospects within this niche segment of the market. |
Here Is Why Bargain Hunters Would Love Fast-paced Mover Accuray (ARAY)If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Accuray (ARAY) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen. |
5 Beaten-Down MedTech Stocks Set to Rebound in 2025Investors may want to take a closer look at discounted stocks, such as MCK, HAE, ARAY, LIVN and PBH, in the present market landscape. |
ARAY Stock Falls Despite Positive Data of CyberKnife in Treating BSMAccuray announces positive study data for its CyberKnife System in treating brainstem metastases. |
Accuray Loses US$24m Market Value But Insiders See Windfall Of US$23kInsiders who bought Accuray Incorporated ( NASDAQ:ARAY ) stock lover the last 12 months are probably not as affected by... |
Accuray reports new data from multicenter analysis of SRS and FSRTAccuray (ARAY) announced international retrospective multicenter analysis found that radiosurgery, or SRS, and fractionated stereotactic radiotherapy, or FSRT, delivered with the CyberKnife System, can provide an effective and time-saving treatment option for brainstem metastases, or BSM. The nine institution study results, published in the International Journal of Cancer, “underscore the long-term benefits in local control and the robust safety profile despite the delicate location of the treat |
New Data Indicates the CyberKnife® System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to TreatAccuray Incorporated (NASDAQ: ARAY) announced today an international retrospective multicenter analysis found that radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT), delivered with the CyberKnife® System, can provide an effective and time-saving treatment option for brainstem metastases (BSM). The nine institution study results, published in the International Journal of Cancer, "underscore the long-term benefits in local control and the robust safety profile despite the delica |
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Accuray (ARAY)If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Accuray (ARAY) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen. |